摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-O-methyl 8-O-(2,2,2-trichloroethyl) (1R,2S,3S,5S)-3-(4-chlorophenyl)-8-azabicyclo[3.2.1]octane-2,8-dicarboxylate | 155509-47-0

中文名称
——
中文别名
——
英文名称
2-O-methyl 8-O-(2,2,2-trichloroethyl) (1R,2S,3S,5S)-3-(4-chlorophenyl)-8-azabicyclo[3.2.1]octane-2,8-dicarboxylate
英文别名
——
2-O-methyl 8-O-(2,2,2-trichloroethyl) (1R,2S,3S,5S)-3-(4-chlorophenyl)-8-azabicyclo[3.2.1]octane-2,8-dicarboxylate化学式
CAS
155509-47-0
化学式
C18H19Cl4NO4
mdl
——
分子量
455.165
InChiKey
RXNWREXNKNXZDX-YJNKXOJESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    503.0±50.0 °C(Predicted)
  • 密度:
    1.440±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and monoamine transporter affinity of front bridged tricyclic 3β-(4′-halo or 4′-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2β-position
    摘要:
    A series of front bridged tricyclic 3 beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2 beta-position was synthesized, and their binding affinities were deter-mined in cells transfected to express human norepinephrine transporter (NET), serotonin transporter (SERT), and dopamine transporter (DAT) via competition binding assays. All compounds studied in this series exhibit a moderate to high potency at all three transporters with SERT or DAT selectivity. 3 beta-(4'-iodo)phenyltropane bearing methylene on the bridge to the 2 beta-position (24) presents a particularly attractive pharmacological profile, with very high SERT affinity (K-i = 0.09 nM) and selectivity versus NET (65-fold) and DAT (94-fold). (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.05.098
  • 作为产物:
    参考文献:
    名称:
    放射性碘化N-(3-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷的合成与表征:潜在的多巴胺重摄取部位成像剂。
    摘要:
    已经开发了用于制备放射性碘化的N-取代的2β-羰甲氧基-3β-(4-氯苯基)托烷的方法。N-(3(Z)-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷(12)和N-的合成,物理性质,放射性标记和药理性质表征描述了(3(E)-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷(13)。2个β-碳甲氧基-3β-(对位取代的苯基)托烷是多巴胺转运蛋白的有效配体。放射性碘化的衍生物是令人关注的,因为高吸收和长纹状体保留可能是由于低容量,高亲和力,多巴胺再摄取位点的特异性结合而引起的。通过相应的3-(三-正丁基锡烷基)的碘脱金属作用,将放射性碘引入N-(3-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷的3Z和3E位置)衍生工具。各种多巴胺重摄取配体与大鼠纹状体组织制剂对[125I] -12或[125I] -13的竞争结合数据表现出以下效力顺序:E-13> Z-12>
    DOI:
    10.1021/jm00036a020
点击查看最新优质反应信息

文献信息

  • Synthesis of novel halo and tosyloxy nortropane derivatives as efficient precursors for the one-step synthesis of the dopamine transporter PET ligand [<sup>18</sup>F]FECNT
    作者:J. Pijarowska-Kruszyna、A. W. Jaron、A. Kachniarz、K. Kasprzak、A. Kowalska、B. Malkowski、S. Demphel、F. Dollé、R. Mikolajczak
    DOI:10.1002/jlcr.3181
    日期:2014.3
    nortropane derivative 2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)-nortropane (FECNT) is a dopamine transporter (DAT) ligand. Currently, it is considered as reference for positron emission tomography imaging. Herein, the synthesis of novel precursors (N-tosyloxy-, chloro-, and bromo- analogues) for one-step radiosynthesis of [(18)F]FECNT is reported. Using the N-mesyloxy- precursor in a one-step
    氟18 标记的nortropane 衍生物2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)-nortropane (FECNT) 是一种多巴胺转运蛋白(DAT) 配体。目前,它被认为是正电子发射断层扫描成像的参考。在此,报道了用于 [(18)F]FECNT 一步放射合成的新型前体(N-甲苯磺酰氧基-、氯-和溴-类似物)的合成。在一步放射合成中使用 N-甲磺酰氧基前体,获得了粗 [(18)F]FECNT,放射性标记率为 45±10%,证实了这种方法在设计新型标记前体方面的实际效率.
  • Chen; Kilts; Camp, Journal of labelled compounds and radiopharmaceuticals, 1999, vol. 42, # SUPPL. 1, p. S400-S402
    作者:Chen、Kilts、Camp、Ely、Keil、Malveaux、Votaw、Hoffman、Goodman
    DOI:——
    日期:——
  • Synthesis and monoamine transporter affinity of front bridged tricyclic 3β-(4′-halo or 4′-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2β-position
    作者:Fanxing Zeng、Nachwa Jarkas、Michael J. Owens、Clinton D. Kilts、Charles B. Nemeroff、Mark M. Goodman
    DOI:10.1016/j.bmcl.2006.05.098
    日期:2006.9
    A series of front bridged tricyclic 3 beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2 beta-position was synthesized, and their binding affinities were deter-mined in cells transfected to express human norepinephrine transporter (NET), serotonin transporter (SERT), and dopamine transporter (DAT) via competition binding assays. All compounds studied in this series exhibit a moderate to high potency at all three transporters with SERT or DAT selectivity. 3 beta-(4'-iodo)phenyltropane bearing methylene on the bridge to the 2 beta-position (24) presents a particularly attractive pharmacological profile, with very high SERT affinity (K-i = 0.09 nM) and selectivity versus NET (65-fold) and DAT (94-fold). (c) 2006 Elsevier Ltd. All rights reserved.
  • Synthesis and Characterization of Radioiodinated N-(3-Iodopropen-1-yl)-2.beta.-carbomethoxy-3.beta.-(4-chlorophenyl)tropanes: Potential Dopamine Reuptake Site Imaging Agents
    作者:Mark M. Goodman、Mei-Ping Kung、George W. Kabalka、Hank F. Kung、Robert Switzer
    DOI:10.1021/jm00036a020
    日期:1994.5
    beta-(p-substituted-phenyl)tropanes are potent ligands for the dopamine transporter. The radioiodinated derivatives are of interest because of the high uptake and prolonged striatal retention that may result from specific binding to low-capacity, high-affinity, dopamine reuptake sites. Radioiodine was introduced into the 3Z and 3E-position of N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropane
    已经开发了用于制备放射性碘化的N-取代的2β-羰甲氧基-3β-(4-氯苯基)托烷的方法。N-(3(Z)-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷(12)和N-的合成,物理性质,放射性标记和药理性质表征描述了(3(E)-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷(13)。2个β-碳甲氧基-3β-(对位取代的苯基)托烷是多巴胺转运蛋白的有效配体。放射性碘化的衍生物是令人关注的,因为高吸收和长纹状体保留可能是由于低容量,高亲和力,多巴胺再摄取位点的特异性结合而引起的。通过相应的3-(三-正丁基锡烷基)的碘脱金属作用,将放射性碘引入N-(3-碘丙烯-1-基)-2β-羰甲氧基-3β-(4-氯苯基)托烷的3Z和3E位置)衍生工具。各种多巴胺重摄取配体与大鼠纹状体组织制剂对[125I] -12或[125I] -13的竞争结合数据表现出以下效力顺序:E-13> Z-12>
查看更多